Asia Pacific Enteral Feeding Formulas Market By Product (Polymeric, Monomeric, Disease-Specific Formulas), By Stage (Adults, Paediatrics), By Application (Oncology, Gastroenterology, Neurology), By End User (Hospitals, LTCS, Home Care) - And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Enteral Feeding Formulas Market By Product (Polymeric, Monomeric, Disease-Specific Formulas), By Stage (Adults, Paediatrics), By Application (Oncology, Gastroenterology, Neurology), By End User (Hospitals, LTCS, Home Care) - And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3334 | Pages: 138 | September 2017 | Region: Asia Pacific


The Asia Pacific Enteral Feeding Devices Market was worth USD 800 million in 2016 and estimated to be growing at a CAGR of 8.9%, to reach USD 1.23 billion by 2021. A growing number of hospitals and ambulatory care services are embracing enteral nutrition as an effective system of clinical nutrition.

Enteral nutrition generally refers to the delivery of nutrients into the gastrointestinal tract through a feeding tube which has been placed by a health care provider. Nutritional needs can be fully met with a tube feeding formula recommended by a healthcare professional. People who cannot or will not voluntarily consume adequate oral nutrition may be candidates for a tube feeding.

The Asia-Pacific enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent.

On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities. The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia.

Some of the prominent players in the global enteral feeding formulas market are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Polymeric

                                5.1.2 Monomeric             

                                5.1.3 Disease-Specific Formulas

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Stage                             

                                5.2.1 Adults       

                                5.2.2 Pediatrics 

                                5.2.3 Y-o-Y Growth Analysis, By Stage    

                                5.2.4 Market Attractiveness Analysis, By Stage  

                                5.2.5 Market Share Analysis, By Stage    

                5.3 Application                 

                                5.3.1 Oncology 

                                5.3.2 Gastroenterology

                                5.3.3 Neurology               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

                5.4 End Users                    

                                5.4.1 Hospitals  

                                5.4.2 LTCS           

                                5.4.3 Home Care              

                                5.4.4 Y-o-Y Growth Analysis, By End Users           

                                5.4.5  Market Attractiveness Analysis, By End Users        

                                5.4.6  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By End Users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Stage

                                                6.1.4.4 By Application

                                                6.1.4.5 By End Users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Stage

                                                6.1.5.4 By Application

                                                6.1.5.5 By End Users

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Nestle S.A.                  

                8.3 Danone S.A.                               

                8.4 Fresenius Kabi AG                   

                8.5 Mead Johnson Nutrition Company                  

                8.6 B. Braun Melsungen AG                        

                8.7 Hormel Foods                            

                8.8 LLC                 

                8.9 Victus Inc.                   

                8.10 Meiji Holdings Co. Ltd.                         

                8.11 Global health Product Inc.                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  2. Asia-Pacific Polymeric Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific Monomeric Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Disease-Specific Formulas Market By Region, From 2016-2021 ( USD Million )
  5. Asia-Pacific Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  6. Asia-Pacific Adults Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific Pediatrics Market By Region, From 2016-2021 ( USD Million )
  8. Asia-Pacific Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  9. Asia-Pacific Oncology Market By Region, From 2016-2021 ( USD Million )
  10. Asia-Pacific Gastroenterology Market By Region, From 2016-2021 ( USD Million )
  11. Asia-Pacific Neurology Market By Region, From 2016-2021 ( USD Million )
  12. Asia-Pacific Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
  13. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  14. Asia-Pacific LTCS Market By Region, From 2016-2021 ( USD Million )
  15. Asia-Pacific Home Care Market By Region, From 2016-2021 ( USD Million )
  16. Japan Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  17. Japan Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  18. Japan Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  19. Japan Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
  20. China Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  21. China Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  22. China Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  23. China Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
  24. India Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  25. India Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  26. India Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  27. India Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
  28. Australia Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  29. Australia Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  30. Australia Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  31. Australia Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
  32. South Korea Enteral Feeding Formulas Market By Product, From 2016-2021 ( USD Million )
  33. South Korea Enteral Feeding Formulas Market By Stage, From 2016-2021 ( USD Million )
  34. South Korea Enteral Feeding Formulas Market By Application, From 2016-2021 ( USD Million )
  35. South Korea Enteral Feeding Formulas Market By End User, From 2016-2021 ( USD Million )
Middle-East And Africa Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Resea...
Latin America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
Asia-Pacific Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Instit...
Europe Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, ...
North America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
ANtibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, Hospita...
Middle-East And Africa Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity As...
Latin America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Asia-Pacific Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tiss...
Europe Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Cu...
North America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture A...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.